SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yao-Chun Hsu, Analyzing Taiwan's National Health Insurance Research Database to explicate the allocation of health-care resources, Advances in Digestive Medicine, 2015,

    CrossRef

  2. 2
    Sheng-Shun Yang, Jia-Horng Kao, Asunaprevir-containing regimens for the treatment of hepatitis C virus infection, Expert Review of Gastroenterology & Hepatology, 2015, 9, 1, 9

    CrossRef

  3. 3
    Naoki Harada, Naoki Hiramatsu, Tsugiko Oze, Tomohide Tatsumi, Norio Hayashi, Tetsuo Takehara, Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma—A retrospective multicenter study, Journal of Medical Virology, 2015, 87, 7
  4. 4
    Teng-Yu Lee, Jaw-Town Lin, Hsiu J. Ho, Ming-Shiang Wu, Chun-Ying Wu, Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation, Radiology, 2015, 141864

    CrossRef

  5. 5
    Yao-Chun Hsu, Chun-Ying Wu, Jaw-Town Lin, Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma, Seminars in Oncology, 2015, 42, 2, 329

    CrossRef

  6. 6
    Jordi Bruix, Kwang-Hyub Han, Gregory Gores, Josep Maria Llovet, Vincenzo Mazzaferro, Liver cancer: Approaching a personalized care, Journal of Hepatology, 2015, 62, 1, S144

    CrossRef

  7. You have free access to this content7
    Naoki Hiramatsu, Tsugiko Oze, Tetsuo Takehara, Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy, Hepatology Research, 2015, 45, 2
  8. 8
    Shozo Mori, Junji Kita, Masato Kato, Mitsugi Shimoda, Keiichi Kubota, Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy, The American Journal of Surgery, 2015, 209, 1, 187

    CrossRef

  9. You have free access to this content9
    Yao-Chun Hsu, Jaw-Town Lin, Hsiu J. Ho, Yu-Hsi Kao, Yen-Tsung Huang, Nai-Wan Hsiao, Ming-Shiang Wu, Yi-Ya Liu, Chun-Ying Wu, Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients, Hepatology, 2014, 59, 4
  10. 10
    Y.-C. Hsu, C.-Y. Wu, H.-Y. Lane, C.-Y. Chang, C.-M. Tai, C.-H. Tseng, G.-H. Lo, D.-S. Perng, J.-T. Lin, L.-R. Mo, Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2014, 69, 7, 1920

    CrossRef

  11. 11
    Gin-Ho Lo, Did postoperative peg-interferon plus ribavirin really reduce recurrence of hepatitis C virus–related hepatocellular carcinoma?, Hepatology, 2014, 59, 4
  12. 12
    J.Y. Lei, W.T. Wang, L.N. Yan, T.F. Wen, B. Li, Radiofrequency Ablation Versus Surgical Resection for Small Unifocal Hepatocellular Carcinomas, Medicine, 2014, 93, 29, e271

    CrossRef

  13. 13
    Yao-Chun Hsu, Chun-Ying Wu, Reply, Hepatology, 2014, 59, 4
  14. 14
    Siddharth Singh, Preet Paul Singh, Lewis R. Roberts, William Sanchez, Chemopreventive strategies in hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 1, 45

    CrossRef

  15. 15
    Jeong Won Jang, Management of viral hepatitis in patients with hepatocellular carcinoma, Journal of the Korean Medical Association, 2013, 56, 11, 1001

    CrossRef

  16. 16
    Nancy Aguilar-Olivos, Sofía Ornelas-Arroyo, Norberto C. Chavez-Tapia, Misael Uribe, Nahum Méndez-Sánchez, New Insights in the Diagnosis, Pathogenesis and Treatment of Hepatitis B- and C-related Hepatocellular Carcinoma, Current Hepatitis Reports, 2013, 12, 4, 297

    CrossRef